Captrust Financial Advisors Exact Sciences Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Exact Sciences Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 9,433 shares of EXAS stock, worth $548,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,433

Previous 7,579 24.46%

Holding current value

$548,151

Previous $320,000 100.63%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $78,665 - $131,318	1,854 Added 24.46%	9,433 $642,000
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $38,726 - $69,581	-937 Reduced 11.0%	7,579 $320,000
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $501,703 - $657,733	-8,916 Reduced 51.15%	8,516 $588,000
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $167,435 - $214,666	2,835 Added 19.42%	17,432 $1.29 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $157,794 - $237,002	-2,393 Reduced 14.08%	14,597 $995,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $25,134 - $38,115	401 Added 2.42%	16,990 $1.6 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $83,762 - $125,616	1,775 Added 11.98%	16,589 $1.12 Million
Q4 2022 Feb 15, 2023	BUY	$30.35 - $53.15 $33,961 - $59,474	1,119 Added 8.17%	14,814 $733,000
Q3 2022 Nov 16, 2022	BUY	$31.97 - $49.37 $92,585 - $142,975	2,896 Added 26.82%	13,695 $445,000
Q2 2022 Aug 23, 2022	SELL	$35.61 - $76.23 $175,165 - $374,975	-4,919 Reduced 31.3%	10,799 $425,000
Q2 2022 Aug 16, 2022	BUY	$35.61 - $76.23 $277,651 - $594,365	7,797 Added 98.43%	15,718 $619,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $40,234 - $57,695	699 Added 9.68%	7,921 $554,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $37,410 - $51,950	516 Added 7.69%	7,222 $562,000
Q3 2021 Nov 16, 2021	BUY	$90.24 - $124.05 $39,254 - $53,961	435 Added 6.94%	6,706 $640,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $13,955 - $20,751	-149 Reduced 2.32%	6,271 $780,000
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $52,456 - $69,754	450 Added 7.54%	6,420 $846,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $33,767 - $48,178	339 Added 6.02%	5,970 $791,000
Q3 2020 Nov 17, 2020	SELL	$72.92 - $102.01 $160,424 - $224,422	-2,200 Reduced 28.09%	5,631 $592,000
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $2,731 - $4,544	-49 Reduced 0.62%	7,831 $685,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $9,588 - $26,423	-253 Reduced 3.11%	7,880 $440,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $491,199 - $630,855	6,325 Added 349.83%	8,133 $777,000
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $2,349 - $3,184	26 Added 1.46%	1,808 $163,000
Q2 2019 Aug 13, 2019	BUY	$89.51 - $118.04 $71,966 - $94,904	804 Added 82.21%	1,782 $210,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $54,418 - $84,727	878 Added 878.0%	978 $85,000
Q3 2017 Feb 16, 2018	BUY	$37.05 - $47.12 $3,704 - $4,712	100	100 $5,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Exact Sciences Corp Transaction History